We are live on ! Find out more
PVMCI

Polaris Venture Management Co IV Portfolio holdings

AUM $62.4M
1-Year Est. Return 33.04%
This Fund
S&P 500
This Quarter Est. Return
-5.96%
1 Year Est. Return
+33.04%
3 Year Est. Return
+52.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$29.1M
Cap. Flow
-$20.2M
Cap. Flow %
-16.48%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
DARE icon
Dare Bioscience
DARE
+$9.25M

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$17.2M
2
TTGT icon
TechTarget
TTGT
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLRN
1
DELISTED
Acceleron Pharma
XLRN
$95.2M 77.81%
2,803,645
-513,491
-15% -$17.2M
ALIM
2
DELISTED
Alimera Sciences
ALIM
$18.8M 15.38%
209,890
– –
DARE icon
3
Dare Bioscience
DARE
$17.4M
$8.34M 6.81%
+11,979
New +$9.25M
TTGT icon
4
TechTarget
TTGT
$327M
– –
-1,699,406
Closed -$12.3M

Similar funds

HCM
Hayman Capital Management Dallas, Texas $63.3M AUM 3.78% 1-Year Est. Return
LVP
Limestone Value Partners Houston, Texas $64M AUM 4.56% 1-Year Est. Return
SVP
Springbank Value Partners Hampton Bays, New York $65.5M AUM 35.56% 1-Year Est. Return
HWM
Heartwood Wealth Management London, United Kingdom $58.9M AUM 14.96% 1-Year Est. Return
CCG
Crescent Capital Group Los Angeles, California $56.8M AUM 11.67% 1-Year Est. Return
CSM
Central Square Management Naperville, Illinois $56.6M AUM 27.75% 1-Year Est. Return
KCP
Keane Capital Partners Charlotte, North Carolina $56M AUM
EL
Elberon LLC Austin, Texas $56M AUM 14.07% 1-Year Est. Return

Polaris Venture Management Co IV's Q2 2014 Portfolio in Review

As of Q2 2014, Polaris Venture Management Co IV held 4 positions worth $122M, down 19% from $152M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co IV withdrew a net $20.2M in Q2 2014, closing 1 position and reducing 1 holding. Its most notable exit was TechTarget, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 92% a quarter earlier, followed by Technology.

Against the trend, Polaris Venture Management Co IV opened a new position in Dare Bioscience worth $8.34M.

  • Polaris Venture Management Co IV's largest Q2 2014 buy was Dare Bioscience: 11,979 shares worth $8.34M.
  • Polaris Venture Management Co IV's biggest Q2 2014 reduction was Acceleron Pharma, cutting an estimated $17.2M.
  • Polaris Venture Management Co IV fully exited TechTarget in Q2 2014, selling an estimated $12.3M.
  • Polaris Venture Management Co IV's ten largest holdings make up 100% of its $122M portfolio in Q2 2014.
  • Polaris Venture Management Co IV opened 1 new position and closed 1 in Q2 2014.
  • Polaris Venture Management Co IV's portfolio value fell 19% quarter-over-quarter to $122M.

Based on Polaris Venture Management Co IV's 13F filing for Q2 2014, filed 11 Aug 2014.